140 related articles for article (PubMed ID: 2378986)
1. Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies.
Borche L; Lim A; Binet JL; Dighiero G
Blood; 1990 Aug; 76(3):562-9. PubMed ID: 2378986
[TBL] [Abstract][Full Text] [Related]
2. Chronic lymphocytic leukemic (CLL) cells secrete multispecific autoantibodies.
Bröker BM; Klajman A; Youinou P; Jouquan J; Worman CP; Murphy J; Mackenzie L; Quartey-Papafio R; Blaschek M; Collins P
J Autoimmun; 1988 Oct; 1(5):469-81. PubMed ID: 2473761
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemia.
Sthoeger ZM; Sthoeger D; Shtalrid M; Sigler E; Geltner D; Berrebi A
Am J Hematol; 1993 Aug; 43(4):259-64. PubMed ID: 7690517
[TBL] [Abstract][Full Text] [Related]
4. IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing.
Wakai M; Hashimoto S; Omata M; Sthoeger ZM; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Diamond B; Dono M
Autoimmunity; 1994; 19(1):39-48. PubMed ID: 7538331
[TBL] [Abstract][Full Text] [Related]
5. Modulation and high frequency expression of autoantibody-associated cross-reactive idiotypes linked to the VHI subgroup in CD5-expressing B lymphocytes from patients with chronic lymphocytic leukaemia (B-CLL).
Shokri F; Mageed RA; Richardson P; Jefferis R
Scand J Immunol; 1993 Jun; 37(6):673-9. PubMed ID: 7686301
[TBL] [Abstract][Full Text] [Related]
6. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia.
Sthoeger ZM; Wakai M; Tse DB; Vinciguerra VP; Allen SL; Budman DR; Lichtman SM; Schulman P; Weiselberg LR; Chiorazzi N
J Exp Med; 1989 Jan; 169(1):255-68. PubMed ID: 2462608
[TBL] [Abstract][Full Text] [Related]
7. Phorbol myristate acetate, but not CD40L, induces the differentiation of CLL B cells into Ab-secreting cells.
Ghamlouch H; Ouled-Haddou H; Guyart A; Regnier A; Trudel S; Claisse JF; Fuentes V; Royer B; Marolleau JP; Gubler B
Immunol Cell Biol; 2014 Aug; 92(7):591-604. PubMed ID: 24797583
[TBL] [Abstract][Full Text] [Related]
8. Idiotypic cross-reactivity of immunoglobulins expressed in Waldenström's macroglobulinemia, chronic lymphocytic leukemia, and mantle zone lymphocytes of secondary B-cell follicles.
Axelrod O; Silverman GJ; Dev V; Kyle R; Carson DA; Kipps TJ
Blood; 1991 Apr; 77(7):1484-90. PubMed ID: 1901234
[TBL] [Abstract][Full Text] [Related]
9. Evidence for somatic selection of natural autoantibodies.
Martin T; Duffy SF; Carson DA; Kipps TJ
J Exp Med; 1992 Apr; 175(4):983-91. PubMed ID: 1552291
[TBL] [Abstract][Full Text] [Related]
10. V gene usage by seven hybrids derived from CD5+ B-cell chronic lymphocytic leukemia and displaying autoantibody activity.
Pritsch O; Magnac C; Dumas G; Egile C; Dighiero G
Blood; 1993 Nov; 82(10):3103-12. PubMed ID: 7693035
[TBL] [Abstract][Full Text] [Related]
11. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
[TBL] [Abstract][Full Text] [Related]
12. Expression and production of cytokines by heterohybrids and their parental B cells in CLL.
Diaw L; Lefebvre d'Hellencourt C; Cornillet I; Vuillier F; Guenounou M; Dighiero G
Leuk Lymphoma; 1996 Apr; 21(3-4):281-91. PubMed ID: 8726409
[TBL] [Abstract][Full Text] [Related]
13. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
[TBL] [Abstract][Full Text] [Related]
14. Basic biology of autoimmune phenomena in chronic lymphocytic leukemia.
Pritsch O; Maloum K; Dighiero G
Semin Oncol; 1998 Feb; 25(1):34-41. PubMed ID: 9482525
[TBL] [Abstract][Full Text] [Related]
15. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
[TBL] [Abstract][Full Text] [Related]
16. Human hybridomas derived from CD5+ B lymphocytes of patients with chronic lymphocytic leukemia (B-CLL) produce multi-specific natural IgM (kappa) antibodies.
Jahn S; Schwab J; Hansen A; Heider H; Schroeder C; Lukowsky A; Achtman M; Matthes H; Kiessig ST; Volk HD
Clin Exp Immunol; 1991 Mar; 83(3):413-7. PubMed ID: 1706236
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody-associated kappa light chain variable region gene expressed in chronic lymphocytic leukemia with little or no somatic mutation. Implications for etiology and immunotherapy.
Kipps TJ; Tomhave E; Chen PP; Carson DA
J Exp Med; 1988 Mar; 167(3):840-52. PubMed ID: 3127527
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells.
Lotz M; Ranheim E; Kipps TJ
J Exp Med; 1994 Mar; 179(3):999-1004. PubMed ID: 8113691
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia.
Allgeier T; Garhammer S; Nössner E; Wahl U; Kronenberger K; Dreyling M; Hallek M; Mocikat R
Cancer Lett; 2007 Jan; 245(1-2):275-83. PubMed ID: 16516377
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin V gene utilization in chronic lymphocytic leukemia and non-Hodgkin's B cell lymphomas.
Kipps TJ
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):293-8. PubMed ID: 3065730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
